Illumina and Merck Partner to ID Cancer Mutations

Submitted by admin on September 8, 2021 - 11:20pm

Source:

Medical Devices and Diagnostics Industry

News Tags:

Headline:

snippet:

Illumina and Merck are collaborating to develop companion diagnostics to identify cancer mutations.

The companion diagnostics will identify genetic mutations used in the assessment of homologous recombination deficiency (HRD).

Search form